IRCT20220418054577N1Completed
The effect of 12 weeks of continuous training and Interval training on oxidative stress and DNA damage in breast cancer survivors
PrivateIranian Registry Of Clinical Trialbehavioral
VerifiedIranian Registry Of Clinical Trial
Study focus
- Disease/Condition
- Malignant neoplasm of breast
- Study type
- Interventional
- Intervention type
- behavioral
Sponsor & location
- Primary sponsor
- Private
- Location
- Iran
Timeline & enrollment
- Phase
- N/A
- Start date
- Aug 22, 2022
- End date
- N/A
ICD-10 classifications
Malignant neoplasm of breastMalignant neoplasm of breastMalignant neoplasm: Breast, unspecifiedMalignant neoplasm: Central portion of breastPersonal history of malignant neoplasm of breast
Data source
- Registry
- Iranian Registry Of Clinical Trial
- Trial ID
- IRCT20220418054577N1
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for IRCT20220418054577N1 through Pure Global AI's free database. This phase not specified trial is sponsored by Private and is currently Completed. The study focuses on Malignant neoplasm of breast.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Iranian Registry Of Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.